Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing Type
4
Filing Date
2/28/2023
Updated
3/1/23, 9:21 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership